Haibo Yu

1.4k total citations
56 papers, 868 citations indexed

About

Haibo Yu is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Haibo Yu has authored 56 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 18 papers in Cellular and Molecular Neuroscience and 15 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Haibo Yu's work include Ion channel regulation and function (24 papers), Cardiac electrophysiology and arrhythmias (15 papers) and Neuroscience and Neuropharmacology Research (13 papers). Haibo Yu is often cited by papers focused on Ion channel regulation and function (24 papers), Cardiac electrophysiology and arrhythmias (15 papers) and Neuroscience and Neuropharmacology Research (13 papers). Haibo Yu collaborates with scholars based in China, United States and Hong Kong. Haibo Yu's co-authors include Beiyan Zou, Owen B. McManus, Man Li, Corey R. Hopkins, Craig W. Lindsley, Meng Wu, Shunyou Long, Min Li, Min Li and J. Scott Daniels and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Journal of Medicinal Chemistry.

In The Last Decade

Haibo Yu

51 papers receiving 856 citations

Peers

Countries citing papers authored by Haibo Yu

Since Specialization

Citations

This map shows the geographic impact of Haibo Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haibo Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haibo Yu more than expected).

Fields of papers citing papers by Haibo Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haibo Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haibo Yu. The network helps show where Haibo Yu may publish in the future.

Co-authorship network of co-authors of Haibo Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Haibo Yu. A scholar is included among the top collaborators of Haibo Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haibo Yu. Haibo Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Grifolic acid, a FFAR4 agonist, identified as a dual antagonist of voltage‐gated sodium and Ca _V 2.2 channels with potent antinociceptive effects 2025 ·British Journal of Pharmacology ·Miao Zhao, (unknown), Jun Wu, Jimei Liu, Min Li, Jungui Dai, Haibo Yu	0
2	Discovery of novel 4-azaindole derivatives as selective Nav1.2 Inhibitor with potent antiepileptic activity and low neurotoxicity 2025 ·European Journal of Medicinal Chemistry ·Bin Lou, (unknown), (unknown), Yuhan Guo, (unknown), Chuanlong Guo, (unknown), Longjiang Huang, Haibo Yu	1
3	SQOR as a metabolic rheostat of H2S: structure, redox homeostasis, and disease therapy 2025 ·Frontiers in Cell and Developmental Biology ·(unknown), Kailun Zhang, (unknown), Hewei Zhang, (unknown), Haibo Yu	0
4	Cerebellum abnormalities in vascular mild cognitive impairment with depression symptom patients: A multimodal magnetic resonance imaging study 2025 ·Brain Research Bulletin ·(unknown), Liling Chen, Li‐Yu Hu, Jianjun Wang, Jinhuan Zhang, (unknown), Jinping Xu, Jianxiang Chen, Haibo Yu	2
5	The electrodynamic analysis and manipulation of PEGDA semicircular tubular structures based on optically induced dielectrophoresis 2024 ·Physica Scripta ·Wenguang Yang, Wenhao Wang, Xiangyu Teng, (unknown), Haibo Yu, Shuxiang Cai	2
6	Full biosynthetic pathway of pyrrolobenzoxazines 2024 ·Chinese Chemical Letters ·(unknown), Bingyu Liu, Daojiang Yan, Jian Bai, Haibo Yu, Youcai Hu	1
7	Schisandrin B from Schisandra chinensis alleviated pain via glycine receptors, Nav1.7 channels and Cav2.2 channels 2024 ·Journal of Ethnopharmacology ·Miao Zhao, Jun Wu, (unknown), Min Li, Ke‐Xin Yu, Haibo Yu	1
8	Design, synthesis, anticonvulsant activity and structure-activity relationships of novel 7-Azaindole derivatives 2023 ·Bioorganic Chemistry ·(unknown), (unknown), Rui Wang, Yu Han, Xiufen Li, Qin Zhang, Zhenpeng Li, Yuexing Wang, Longjiang Huang, Haibo Yu	10
9	Structural diversification of phenylspirodrimane lactams by employing a biosynthetic intermediate 2023 ·Chinese Chemical Letters ·Jimei Liu, Zhenfei Wang, Jun Wu, (unknown), (unknown), Tiantai Zhang, Haibo Yu, Zhengshun Wen, Jungui Dai	0
10	Phytol from Faeces Bombycis alleviated migraine pain by inhibiting Nav1.7 sodium channels 2023 ·Journal of Ethnopharmacology ·Jianan Song, Mengyuan Jiang, (unknown), (unknown), Yanhong Li, Yumei Liu, Haibo Yu, Xiang‐Zhong Huang	3
11	Voltage-dependent potassium channel Kv4.2 alleviates the ischemic stroke impairments through activating neurogenesis 2021 ·Neurochemistry International ·(unknown), (unknown), (unknown), Haibo Yu, (unknown), Mengyao Li, (unknown), (unknown), Sihan Wang, (unknown), Rui Zhao, Aixue Li, (unknown), (unknown), (unknown), Libo Du, (unknown), Qun Yu, Liu Yang, Yuming Zhao	5
12	Identification of WP1066, an inhibitor of JAK2 and STAT3, as a K_V1.3 potassium channel blocker 2021 ·British Journal of Pharmacology ·Min Li, Haibo Yu	7
13	Depletion of NK cells attenuates paraquat-induced acute lung injury by manipulating macrophage polarization 2020 ·International Immunopharmacology ·Mingyu Wu, Chunyu Zhou, (unknown), Haibo Yu, Dake Zhao, Xue Wen, Ling Qin, Ai Peng	16
14	Discovery of [1,2,4]-triazolo [1,5-a]pyrimidine-7(4H)-one derivatives as positive modulators of GABAA1 receptor with potent anticonvulsant activity and low toxicity 2019 ·European Journal of Medicinal Chemistry ·Longjiang Huang, Jing Ding, Min Li, Zhipeng Hou, (unknown), Xiufen Li, Haibo Yu	41
15	Loperamide inhibits sodium channels to alleviate inflammatory hyperalgesia 2017 ·Neuropharmacology ·Ying Wu, Beiyan Zou, Lingli Liang, Min Li, Yuan‐Xiang Tao, Haibo Yu, Xiaoliang Wang	16
16	Global Analysis Reveals Families of Chemical Motifs Enriched for hERG Inhibitors 2015 ·PLoS ONE ·Fang Du, (unknown), Haibo Yu, Beiyan Zou, Man Li	9
17	Modulation of hERG potassium channel gating normalizes action potential duration prolonged by dysfunctional KCNQ1 potassium channel 2012 ·Proceedings of the National Academy of Sciences ·Hongkang Zhang, Beiyan Zou, Haibo Yu, Alessandra Moretti, Xiaoying Wang, Wei Yan, (unknown), Milena Bellin, Owen B. McManus, Gordon F. Tomaselli, Fajun Nan, Karl‐Ludwig Laugwitz, Min Li	46
18	hERGCentral: A Large Database to Store, Retrieve, and Analyze Compound-Human Ether-à-go-go Related Gene Channel Interactions to Facilitate Cardiotoxicity Assessment in Drug Development 2011 ·Assay and Drug Development Technologies ·Fang Du, Haibo Yu, Beiyan Zou, (unknown), Shunyou Long, Man Li	41
19	Profiling Diverse Compounds by Flux- and Electrophysiology-Based Primary Screens for Inhibition of Human Ether-à-go-go Related Gene Potassium Channels 2010 ·Assay and Drug Development Technologies ·Beiyan Zou, Haibo Yu, (unknown), (unknown), Joel S. Bader, Owen B. McManus, Man Li	23
20	Cesium Effects on if and iK in Rabbit Sinoatrial Node Myocytes: Implications for SA Node Automaticity 1998 ·Journal of Cardiovascular Pharmacology ·(unknown), Haibo Yu, (unknown), Ira S. Cohen, Mario Vassalle	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact